Shuttle Pharmaceuticals (SHPH) Income Statement (2021 - 2026)
Income Statement report data from Mar 31, 2021 to Mar 31, 2026 for Shuttle Pharmaceuticals (SHPH).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Expenses | |||||||||||||||||||
Research And Development | 270K (-47.06%) | 510K (-45.74%) | 940K (-8.74%) | 1.03M (-34.39%) | 1.57M (+12.14%) | 1.40M (+115.38%) | 650K (+10.17%) | 590K (-43.81%) | 1.05M (+25.00%) | 840K (-16.83%) | 1.01M (+129.55%) | 440K (-34.33%) | 670K (+737.50%) | 80K (-73.33%) | 300K (-63.86%) | 830K (+336.84%) | 190K | - | - |
Selling General And Administrative | 1.16M (-36.96%) | 1.84M (+106.74%) | 890K (-62.13%) | 2.35M (+291.67%) | 600K (+81.82%) | 330K (+6.45%) | 310K (-3.13%) | 320K (+18.52%) | 270K (+28.57%) | 210K (+23.53%) | 170K (+88.89%) | 90K (+12.50%) | 80K (+700.00%) | 10K (0.00%) | 10K (-66.67%) | 30K (+200.00%) | 10K | - | - |
Operating Expenses | 2.22M (-20.43%) | 2.79M (+22.91%) | 2.27M (-41.94%) | 3.91M (+32.54%) | 2.95M (-3.28%) | 3.05M (+106.08%) | 1.48M (+7.25%) | 1.38M (-13.75%) | 1.60M (+8.84%) | 1.47M (-4.55%) | 1.54M (+108.11%) | 740K (-9.76%) | 820K (+134.29%) | 350K (-45.31%) | 640K (-57.33%) | 1.50M (+525.00%) | 240K | - | - |
Depreciation And Amortization | 630K (+117.24%) | 290K | - | - | - | - | - | - | - | - | - | - | - | - | - | 10K | - | - | - |
Operating Income | |||||||||||||||||||
Operating Income | -2.22M (-20.43%) | -2.79M (+22.91%) | -2.27M (-41.94%) | -3.91M (+32.54%) | -2.95M (-3.28%) | -3.05M (+106.08%) | -1.48M (+7.25%) | -1.38M (-13.75%) | -1.60M (+8.84%) | -1.47M (-4.55%) | -1.54M (+108.11%) | -740.00K (-9.76%) | -820.00K (+134.29%) | -350.00K (-45.31%) | -640.00K (-57.33%) | -1.50M (+525.00%) | -240.00K | - | - |
Ebit | -2.22M (-20.43%) | -2.79M (+22.91%) | -2.27M (-41.94%) | -3.91M (+32.54%) | -2.95M (-3.28%) | -3.05M (+106.08%) | -1.48M (+7.25%) | -1.38M (-13.75%) | -1.60M (+8.84%) | -1.47M (-4.55%) | -1.54M (+108.11%) | -740.00K (-9.76%) | -820.00K (+134.29%) | -350.00K (-45.31%) | -640.00K (-37.25%) | -1.02M (+325.00%) | -240.00K (-31.43%) | -350.00K (+169.23%) | -130.00K |
EBITDA | -1.58M (-39.69%) | -2.62M (+11.49%) | -2.35M (-36.66%) | -3.71M (+25.76%) | -2.95M (-21.96%) | -3.78M (+130.49%) | -1.64M (+18.84%) | -1.38M (+17.95%) | -1.17M (-28.66%) | -1.64M (+6.49%) | -1.54M (+67.39%) | -920.00K (+135.90%) | -390.00K (-35.00%) | -600.00K (-6.25%) | -640.00K (-38.46%) | -1.04M (+372.73%) | -220.00K (-37.14%) | -350.00K (+169.23%) | -130.00K |
Other Income / Expenses | |||||||||||||||||||
Interest Income | - | - | - | - | - | - | 10K (-50.00%) | 20K (0.00%) | 20K (0.00%) | 20K (0.00%) | 20K | - | - | - | - | - | - | - | - |
Interest Expense | - | - | - | - | - | - | 390K (-13.33%) | 450K (-27.42%) | 620K (+12.73%) | 550K (+19.57%) | 460K (+48.39%) | 310K (-48.33%) | 600K | - | - | - | - | - | - |
Net Interest Income | - | - | - | - | - | - | 10K (-50.00%) | 20K | -600.00K | 20K (0.00%) | 20K | - | - | - | - | - | - | - | - |
Other Non Operating Income | 60K (-70.00%) | 200K | -80.00K | 200K | -100.00K (-86.30%) | -730.00K (+32.73%) | -550.00K (+57.14%) | -350.00K (+84.21%) | -190.00K (-73.61%) | -720.00K | 570K | -470.00K (+161.11%) | -180.00K (-25.00%) | -240.00K (+500.00%) | -40.00K | 590K (+1866.67%) | 30K | - | - |
Net Income | |||||||||||||||||||
Income Before Tax | - | - | - | - | - | - | - | - | -1.78M | - | -980.00K (-27.41%) | -1.35M (+35.00%) | -1.00M | - | -680.00K (-27.66%) | -940.00K (+327.27%) | -220.00K | - | - |
Net Income From Continuing Operations | -2.15M (-17.62%) | -2.61M (+11.06%) | -2.35M (-36.66%) | -3.71M (+21.64%) | -3.05M (-19.31%) | -3.78M (+86.21%) | -2.03M (+17.34%) | -1.73M (-3.35%) | -1.79M (-17.89%) | -2.18M (+122.45%) | -980.00K (+30.67%) | -750.00K (-25.00%) | -1.00M (+66.67%) | -600.00K (-11.76%) | -680.00K (+47.83%) | -460.00K (+109.09%) | -220.00K (-37.14%) | -350.00K (+169.23%) | -130.00K |
Net Income | -2.15M (-17.62%) | -2.61M (+11.06%) | -2.35M (-36.66%) | -3.71M (+21.64%) | -3.05M (-19.31%) | -3.78M (+86.21%) | -2.03M (+17.34%) | -1.73M (-3.35%) | -1.79M (-17.89%) | -2.18M (+122.45%) | -980.00K (+30.67%) | -750.00K (-25.00%) | -1.00M (+66.67%) | -600.00K (-11.76%) | -680.00K (+47.83%) | -460.00K (+109.09%) | -220.00K (-37.14%) | -350.00K (+169.23%) | -130.00K |